Chembio Diagnostics’ CFO Richard J. Larkin Among the Recipients of “2011 CFO of the Year” Award from Long Island Business News

MEDFORD, N.Y., Aug. 18, 2011 /PRNewswire/ — Richard Larkin,
Chief Financial Officer of Chembio Diagnostics, Inc. (OTCQB: CEMI)
(OTC.BB: CEMI), which develops, manufactures, markets and licenses
point-of-care diagnostic tests, is among the recipients of the
“2011 CFO of the Year” award from Long Island Business News
(LIBN).  A total of 27 CFOs were awarded the honor this
year.  Among the honorees, Mr. Larkin was one of two CFOs of a
public company with revenue under $50 million.    

Mr. Larkin was awarded the honor by LIBN judges, who
chose him based on the critical role he has played in Chembio’s
success.  The award program acknowledges “the outstanding
performance, contributions and accomplishments of the financial
professionals guiding Long Island’s companies and organizations.”
 Mr. Larkin oversees Chembio’s financial activities and
information systems, and has been the Chief Financial Officer since
September 2003.

Mr. Larkin and the other 2011 recipients will be honored at a
special gala at The Crest Hollow Country Club in Woodbury, NY on
the evening of Thursday, September 22.

Larry Siebert, Chairman and Chief Executive Officer of Chembio,
commented: “Rich Larkin has been a tremendous asset to our entire
organization since he joined us in 2003, and has played a critical
role in the growth of our company.  We would like to thank the
judges at Long Island Business News for acknowledging
Richard, and congratulate the other recipients of the award this
year.”

About Chembio Diagnostics

Chembio Diagnostics, Inc. develops, manufactures, licenses and
markets proprietary rapid diagnostic tests in the growing $7
billion point-of-care testing market. Chembio’s two FDA
PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S.
by Alere, Inc. Chembio markets its HIV STAT-PAK® line of rapid
HIV tests internationally to governme

‘/>”/>

SOURCE